Cellmid (ASX:CDY) Chief Executive and Managing Director Maria Halasz sat down with Christine Corrado from Proactive Investors New York to discuss their biotech company that now has products available in the United States.
Halasz telling Proactive they are about to spin out into 2 companies and she sees the company becoming profitable in 2020.